Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study (PEACE)

September 12, 2016 updated by: Centre Hospitalier Universitaire de Besancon
This study aims to investigate whether follow-up with a psychologist has an impact on the outcome of patients with an implantable automated defibrillator.

Study Overview

Detailed Description

The implantation of an ICD in primary prevention is known to increase the rates of anxiety and depression, which can reach up to 45% and 35% respectively in this patient population. Several studies have reported that psychological accompaniment for these patients can alleviate the symptoms of anxiety and/or depression. Therefore, we aim to investigate the utility of psychological follow-up for a period of 1 year after first implantation of an ICD for primary prevention.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Besancon, France, 25000
        • CHU Besançon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult patients (aged 18 years or over)
  • indication for implantation of an ICD for primary prophylaxis
  • written informed consent provided
  • patients with social security coverage

Exclusion Criteria:

  • patients under legal tutorship or guardianship
  • patients with no social security coverage
  • patients still within the exclusion period after participation in another clinical trial, as indicated by the national registry of clinical trial volunteers
  • patients unable to complete the questionnaires (language barriers, mentally deficient, illiteracy or dementia)
  • patients awaiting heart transplant
  • patients who refuse to provide written informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychological follow-up
Patients undergoing implantation of an ICD for primary prevention will have an individual interview with a qualified psychologist in addition to standard medical follow-up.
Individual, recorded interview with a qualified psychologist to discuss any and all subjects related to the ICD implantation, or any other topics deemed relevant by the patient.
No Intervention: Control
Patients undergoing implantation of an ICD for primary prevention will have standard medical follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mini International Neuropsychiatric Interview score
Time Frame: 48 hours after implantation
48 hours after implantation
Mini International Neuropsychiatric Interview score
Time Frame: 2 weeks after implantation
2 weeks after implantation
Mini International Neuropsychiatric Interview score
Time Frame: 2 months after implantation
2 months after implantation
Mini International Neuropsychiatric Interview score
Time Frame: 4 months after implantation
4 months after implantation
Mini International Neuropsychiatric Interview score
Time Frame: 6 months after implantation
6 months after implantation
Mini International Neuropsychiatric Interview score
Time Frame: 12 months after implantation
12 months after implantation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 48 hours after implantation
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
48 hours after implantation
Quality of life
Time Frame: 2 weeks after implantation
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
2 weeks after implantation
Quality of life
Time Frame: 2 months after implantation
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
2 months after implantation
Quality of life
Time Frame: 4 months after implantation
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
4 months after implantation
Quality of life
Time Frame: 6 months after implantation
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
6 months after implantation
Quality of life
Time Frame: 12 months after implantation
Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire
12 months after implantation
State-Trait Anxiety Inventory
Time Frame: 48 hours after implantation
Measure of state and trait anxiety
48 hours after implantation
State-Trait Anxiety Inventory
Time Frame: 2 weeks after implantation
Measure of state and trait anxiety
2 weeks after implantation
State-Trait Anxiety Inventory
Time Frame: 2 months after implantation
Measure of state and trait anxiety
2 months after implantation
State-Trait Anxiety Inventory
Time Frame: 4 months after implantation
Measure of state and trait anxiety
4 months after implantation
State-Trait Anxiety Inventory
Time Frame: 6 months after implantation
Measure of state and trait anxiety
6 months after implantation
State-Trait Anxiety Inventory
Time Frame: 12 months after implantation
Measure of state and trait anxiety
12 months after implantation
Minnesota Living with Heart Failure questionnaire
Time Frame: 48 hours after implantation
Evaluation of the quality of life in patients with heart failure
48 hours after implantation
Minnesota Living with Heart Failure questionnaire
Time Frame: 2 weeks after implantation
Evaluation of the quality of life in patients with heart failure
2 weeks after implantation
Minnesota Living with Heart Failure questionnaire
Time Frame: 2 months after implantation
Evaluation of the quality of life in patients with heart failure
2 months after implantation
Minnesota Living with Heart Failure questionnaire
Time Frame: 4 months after implantation
Evaluation of the quality of life in patients with heart failure
4 months after implantation
Minnesota Living with Heart Failure questionnaire
Time Frame: 6 months after implantation
Evaluation of the quality of life in patients with heart failure
6 months after implantation
Minnesota Living with Heart Failure questionnaire
Time Frame: 12 months after implantation
Evaluation of the quality of life in patients with heart failure
12 months after implantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexandre Guignier, MD, Centre Hospitalier Universitaire de Besancon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

September 1, 2016

First Submitted That Met QC Criteria

September 12, 2016

First Posted (Estimate)

September 15, 2016

Study Record Updates

Last Update Posted (Estimate)

September 15, 2016

Last Update Submitted That Met QC Criteria

September 12, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implantable Defibrillator User

Clinical Trials on Individual interview with a qualified psychologist

Subscribe